You will be shocked. Part 1 with Carol Keihn

A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS

Study Sponsor: BioNTechStudy Conducted By: PfizerStudy Intervention Number: PF-07302048Study Intervention Name: RNA-Based COVID-19 VaccinesUS IND Number: 19736EudraCT Number: 2020-002641-42Protocol Number: C4591001Phase: 1/2/3Short Title: A Phase 1/2/3 Study to...